Immune response to B19 parvovirus and an antibody defect in persistent viral infection.
B19 parvovirus has been shown to persist in some immunocompromised patients, and treatment with specific antibodies can lead to decreased quantities of circulating virus and hematologic improvement. A defective immune response to B19 parvovirus in these patients was shown by comparison of results us...
Gardado en:
| Publicado en: | J Clin Invest |
|---|---|
| Principais autores: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Society for Clinical Investigation
1989
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC329767/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2551923/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI114274 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|